06.01.15
Anacor Pharmaceuticals has named Graeme Bell as its new executive vice president and chief financial officer. Mr. Bell has more than 20 years of global financial experience in the pharmaceutical industry, and will succeed Geoffrey Parker as of June 1, 2015. Mr. Parker will remain with Anacor as a consultant to support the transition. Mr. Bell joins Anacor from Merck where he served since 2010 as its vice president, country chief financial officer, U.S. human health, responsible for the financial oversight and support of Merck’s U.S. pharmaceutical and vaccine business.